These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Antigenic specificity of the cytolytic T lymphocyte (CTL) response to murine sarcoma virus-induced tumors. I. Preferential reactivity of in vitro generated secondary CTL with syngeneic tumor cells. Plata F; Jongeneel V; Cerottini JC; Brunner KT Eur J Immunol; 1976 Nov; 6(11):823-9. PubMed ID: 187429 [TBL] [Abstract][Full Text] [Related]
5. Specific lysis of murine cells expressing HLA molecules by allospecific human and murine H-2-restricted anti-HLA T killer lymphocytes. Achour A; Begue B; Gomard E; Paul P; Sayagh B; Van Pel A; Levy JP Eur J Immunol; 1986 Jun; 16(6):597-604. PubMed ID: 3522244 [TBL] [Abstract][Full Text] [Related]
6. Specific induction of syngeneic cytotoxic T lymphocytes by solubilized tumor antigen: fractionation of the specific R-MuLV-induced leukemia antigen. Alaba O; Law LW J Immunol; 1980 Jul; 125(1):414-9. PubMed ID: 6155403 [TBL] [Abstract][Full Text] [Related]
7. Studies on the cytolytic attack mechanism of the cytotoxic T lymphocyte (CTL): preparation of antisera against cellfree cytosolic extracts of a CTL clone capable of blocking the lethal hit stage of CTL cytolysis and analysis of the cytolytic structure. Hiserodt JC J Immunol; 1985 Jul; 135(1):53-62. PubMed ID: 3158707 [TBL] [Abstract][Full Text] [Related]
8. Cross-reacting antigens on L5178Y cells which serve as targets for cytotoxic T-lymphocyte lysis during establishment of the tumor dormant state. Weinhold KJ; Wheelock EF Cancer Res; 1982 Sep; 42(9):3607-16. PubMed ID: 6179603 [TBL] [Abstract][Full Text] [Related]
9. The induction of cytolytic T lymphocytes with purified plasma membranes. Lemonnier F; Mescher TM; sherman L; Burakoff S J Immunol; 1978 Apr; 120(4):1114-20. PubMed ID: 76660 [TBL] [Abstract][Full Text] [Related]
10. Loss of reactivity of a BALB/c myeoloma tumor with allogeneic and syngeneic cytotoxic T lymphocytes. Russel JH; Hale AH; Inbar D; Eisen HN Eur J Immunol; 1978 Sep; 8(9):640-5. PubMed ID: 309400 [TBL] [Abstract][Full Text] [Related]
11. Stimulation of different pathways of T-cell functions by syngeneic tumor cells and soluble membrane proteins. Bertschmann M; Lüscher EF Cell Immunol; 1983 May; 78(1):13-22. PubMed ID: 6602000 [TBL] [Abstract][Full Text] [Related]
12. Quantitative variations in the expression of H-2 antigens on murine leukemia virus-induced tumor cells can affect the H-2 restriction patterns of tumor-specific cytolytic T lymphocytes. Plata F; Tilkin AF; Lévy JP; Lilly F J Exp Med; 1981 Dec; 154(6):1795-810. PubMed ID: 6172533 [TBL] [Abstract][Full Text] [Related]
13. Interaction of cytotoxic T lymphocytes with target cells. I. Specific inhibition by detergent-solubilized, partially purified mouse histocompatibility antigens. Whisnant CC; Singer KH; Amos DB J Immunol; 1978 Dec; 121(6):2253-6. PubMed ID: 309895 [TBL] [Abstract][Full Text] [Related]
14. Cellular interactions in the generation of cytolytic T lymphocyte responses: role of Ia-positive splenic adherent cells in presentation in H-2 antigen. Weinberger O; Herrmann SH; Mescher MF; Benacerraf B; Burakoff SJ Proc Natl Acad Sci U S A; 1980 Oct; 77(10):6091-5. PubMed ID: 6969401 [TBL] [Abstract][Full Text] [Related]
15. T-cell-mediated cytotoxic immune responses to F9 teratocarcinoma cells: cytolytic effector T cells lyse H-2-negative F9 cells and syngeneic spermatogonia. Wagner H; Starzinski-Powitz A; Röllinghoff M; Golstein P; Jakob H J Exp Med; 1978 Jan; 147(1):251-64. PubMed ID: 415107 [TBL] [Abstract][Full Text] [Related]
16. Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. IV. Analysis of variant-specific antigens by selection of antigen-loss variants with cytolytic T cell clones. Maryanski JL; Boon T Eur J Immunol; 1982 May; 12(5):406-12. PubMed ID: 6178608 [TBL] [Abstract][Full Text] [Related]
17. Specificity studies on cytolytic T lymphocytes directed against murine leukemia virus-induced tumors. Analysis of monoclonal cytolytic T lymphocytes. Plata F J Exp Med; 1982 Apr; 155(4):1050-62. PubMed ID: 6174669 [TBL] [Abstract][Full Text] [Related]
18. Rauscher leukemia virus-induced tumor antigens: complete separation from gp70, p30 and H-2. Alaba O; Rogers MJ; Law LW Int J Cancer; 1979 Nov; 24(5):608-15. PubMed ID: 93583 [TBL] [Abstract][Full Text] [Related]
19. Tumors induced by murine sarcoma virus contain precursor cells capable of generating tumor-specific cytolytic T lymphocytes. Chapdelaine JM; Plata F; Lilly F J Exp Med; 1979 Jun; 149(6):1531-6. PubMed ID: 221614 [TBL] [Abstract][Full Text] [Related]
20. Phenotypic and functional properties of murine thymocytes. I. Precursors of cytolytic T lymphocytes and interleukin 2-producing cells are all contained within a subpopulation of "mature" thymocytes as analyzed by monoclonal antibodies and flow microfluorometry. Ceredig R; Glasebrook AL; MacDonald HR J Exp Med; 1982 Feb; 155(2):358-79. PubMed ID: 6120202 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]